These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22553975)

  • 1. Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.
    Thumma SR; Fairbanks RK; Lamoreaux WT; Mackay AR; Demakas JJ; Cooke BS; Elaimy AL; Hanson PW; Lee CM
    World J Surg Oncol; 2012 May; 10():75. PubMed ID: 22553975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of race on the prognosis of the glioblastoma patient: a brief review.
    Patel NP; Lyon KA; Huang JH
    Neurol Res; 2019 Nov; 41(11):967-971. PubMed ID: 31271539
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.
    Shabihkhani M; Telesca D; Movassaghi M; Naeini YB; Naeini KM; Hojat SA; Gupta D; Lucey GM; Ontiveros M; Wang MW; Hanna LS; Sanchez DE; Mareninov S; Khanlou N; Vinters HV; Bergsneider M; Nghiemphu PL; Lai A; Liau LM; Cloughesy TF; Yong WH
    J Neurooncol; 2017 Apr; 132(2):351-358. PubMed ID: 28161760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
    Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved treatment of glioblastoma - changes in survival over two decades at a single regional Centre.
    Eriksson M; Kahari J; Vestman A; Hallmans M; Johansson M; Bergenheim AT; Sandström M
    Acta Oncol; 2019 Mar; 58(3):334-341. PubMed ID: 30732527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
    Wen J; Chen W; Zhu Y; Zhang P
    BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of care and outcomes of chemoradiation versus radiation alone for MGMT promoter unmethylated glioblastoma.
    Lee A; Malakhov N; Sheth N; Wang A; Han P; Schreiber D
    Clin Neurol Neurosurg; 2018 Jul; 170():127-131. PubMed ID: 29777945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
    Kozak KR; Moody JS
    Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas.
    Gessler F; Bernstock JD; Braczynski A; Lescher S; Baumgarten P; Harter PN; Mittelbronn M; Wu T; Seifert V; Senft C
    Neurosurgery; 2019 Jan; 84(1):190-197. PubMed ID: 29617848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
    Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
    J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?
    Heiland DH; Haaker G; Watzlawick R; Delev D; Masalha W; Franco P; Machein M; Staszewski O; Oelhke O; Nicolay NH; Schnell O
    J Neurooncol; 2018 Nov; 140(2):385-391. PubMed ID: 30076585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Survival Outcomes Between Partial Resection and Biopsy for Primary Glioblastoma: A Propensity Score-Matched Study.
    Byun J; Kim YH; Nam SJ; Park JE; Cho YH; Kim HS; Hong SH; Kim JH; Kim SJ; Kim CJ
    World Neurosurg; 2019 Jan; 121():e858-e866. PubMed ID: 30315970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
    Sampson JH; Heimberger AB; Archer GE; Aldape KD; Friedman AH; Friedman HS; Gilbert MR; Herndon JE; McLendon RE; Mitchell DA; Reardon DA; Sawaya R; Schmittling RJ; Shi W; Vredenburgh JJ; Bigner DD
    J Clin Oncol; 2010 Nov; 28(31):4722-9. PubMed ID: 20921459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.
    Lötsch D; Ghanim B; Laaber M; Wurm G; Weis S; Lenz S; Webersinke G; Pichler J; Berger W; Spiegl-Kreinecker S
    Neuro Oncol; 2013 Apr; 15(4):423-32. PubMed ID: 23393205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO).
    Leibetseder A; Ackerl M; Flechl B; Wöhrer A; Widhalm G; Dieckmann K; Kreinecker SS; Pichler J; Hainfellner J; Preusser M; Marosi C
    Neuro Oncol; 2013 Jan; 15(1):112-21. PubMed ID: 23223340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database.
    Frandsen J; Orton A; Jensen R; Colman H; Cohen AL; Tward J; Shrieve DC; Suneja G
    J Neurosurg; 2018 Apr; 128(4):1133-1138. PubMed ID: 28621623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.
    Kim YS; Kim SH; Cho J; Kim JW; Chang JH; Kim DS; Lee KS; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):661-7. PubMed ID: 22414280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.
    Pan IW; Ferguson SD; Lam S
    J Clin Neurosci; 2015 Oct; 22(10):1575-81. PubMed ID: 26122381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.
    Darefsky AS; King JT; Dubrow R
    Cancer; 2012 Apr; 118(8):2163-72. PubMed ID: 21882183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.